Recipient Title General Manager – Quality, New Survey No. 211, Village Account No. 170 Old Block Survey No. 158, Bavla, Taulka Mauje Ahmedabad 382220 Gujarat IndiaFEI 3035187076Issued Jun 2, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3035187076.
Violations4
Issue DateJun 2, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
Umendra Life Sciences Private Limited
Location
Recipient Title General Manager – Quality, New Survey No. 211, Village Account No. 170 Old Block Survey No. 158, Bavla, Taulka Mauje Ahmedabad 382220 Gujarat India
FEI Number
3035187076
Country
India
Issue Date
June 02, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
CGMP/OTC Finished Pharmaceuticals/Adulterated
Umendra Life Sciences Private Limited FDA Warning Letter, June 2, 2026
Talk to a Specialist